FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

SSM Health Care St. Louis DBA SSM St. Clare Health Center Fentanyl 2 mcg/mL and ropivacaine 0 Recall

Fentanyl 2 mcg/mL and ropivacaine 0

SSM Health Care St. Louis DBA SSM St. Clare Health Center · Fenton, MO

Risk level
Class II
Reported by FDA
Jan 3, 2018
Recall ID
D-0138-2018
Check your lot numberHow we source this data

Summary

SSM Health Care St. Louis DBA SSM St. Clare Health Center recalled Fentanyl 2 mcg/mL and ropivacaine 0 starting Aug 10, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0138-2018 on Jan 3, 2018. Reason: Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms. Status: Terminated.

Why it was recalled

Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.

Product description

Fentanyl 2 mcg/mL and ropivacaine 0.2% in 0.9% Sodium Chloride 150 mL, 150 mL bag, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88883-4272-01

Lot numbers, UPCs & expiration codes

Lot, exp: 170621-008, 09/19/2017; 170703-002, 10/01/2017; 170711-031, 10/09/2017

Where it was sold

SSM Health entities in the state of MO only

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0138-2018
Classification
Class II
Status
Terminated
Recall initiated
Aug 10, 2017
FDA report date
Jan 3, 2018
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
SSM Health Care St. Louis DBA SSM St. Clare Health Center

Original FDA data

Every field from FDA enforcement report D-0138-2018, exactly as published.

Show all FDA fields
City
Fenton
State
MO
Status
Terminated
Country
United States
Event ID
78678
Address
1015 Bowles Ave
Code information
Lot, exp: 170621-008, 09/19/2017; 170703-002, 10/01/2017; 170711-031, 10/09/2017
Postal code
63026-2394
Report date
Jan 3, 2018
Product type
Drugs
Recall number
D-0138-2018
Classification
Class II
Recalling firm
SSM Health Care St. Louis DBA SSM St. Clare Health Center
Termination date
Mar 22, 2018
Reason for recall
Lack of sterility assurance: Microbial growth detected during a routine simulation of the manufacturing process. No batches of distributed product have been identified as actually containing microorganisms.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Fentanyl 2 mcg/mL and ropivacaine 0.2% in 0.9% Sodium Chloride 150 mL, 150 mL bag, This is a compounded injectable drug; Rx only; Hospital/office use only. SSM St. Clare Outsourcing Facility, Fenton, MO. --- NDC: 88883-4272-01
Distribution pattern
SSM Health entities in the state of MO only
Recall initiation date
Aug 10, 2017
Initial firm notification
E-Mail
Center classification date
Dec 28, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0138-2018, published Jan 3, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls